The escalating war in the Mideast so far has not appreciably disrupted global pharmaceutical supply chains, but with no clear end in sight, the potential exists for the conflict to change the calculus for production, shipping and, ultimately, pricing for different medicines in different countries, according to industry experts.
For now, the greatest impact is likely to occur in the immediate region, where only a smidgen of the world’s medicines and active pharmaceutical ingredients – 0.3% and 0.6%, respectively – are produced, according to US Pharmacopeia, an independent organization that develops standards for medicines and tracks global supplies.Read the rest…